Oncolytic measles virus encoding thyroidal sodium iodide symporter (Vyriad)

N/A

Report date: 2022/10/14 20:00:43

Base Information

Drug NameOncolytic measles virus encoding thyroidal sodium iodide symporter (Vyriad)
Drug Alias NameSodium Iodide Simporter Measles VirusMVvac2N-ISNSC-731414MV-NIS
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulantsCell death stimulants
TargetsNot applicable
Therapy Area/IndicationsFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVyriad
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteVyriad Inc
Inactive CompaniesN/A
Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[7] 
Inactive IndicationsCarcinoma, Non-Small-Cell LungMultiple MyelomaCholangiocarcinoma +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia